Apr. 3 at 11:32 AM
$BLGO Note the lock up agreement for the recent options payment- VERY bullish: BIOLARGO, INC. Chief Science Officer Kenneth Reay Code received a grant of 69,444 shares of common stock at an acquisition price of
$0.162 per share. The award was issued in exchange for reduced salary and unreimbursed business expenses.
The shares are subject to a lock-up agreement and cannot be sold until the company reports at least
$40 million in gross revenue for any quarter or year, or its market capitalization exceeds
$300 million, or there is a change in control. Following this grant, his total holdings are 25,875,752 shares, including 22,139,012 shares held indirectly through a wholly owned corporation.